BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 28887755)

  • 1. Prokinetics in the Management of Functional Gastrointestinal Disorders.
    Quigley EMM
    Curr Gastroenterol Rep; 2017 Sep; 19(10):53. PubMed ID: 28887755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacologic treatments of transit disorders].
    Manz M; Meier R
    Ther Umsch; 2007 Apr; 64(4):227-32. PubMed ID: 17663210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
    Sanger GJ; Alpers DH
    Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development Conference.
    Howden CW; Vakil NB
    Gastroenterology; 2017 Mar; 152(4):e1-e4. PubMed ID: 28147223
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of Prokinetics on the Digestive Tract.
    Usai-Satta P; Lai M; Oppia F; Cabras F
    Curr Rev Clin Exp Pharmacol; 2022; 17(3):161-165. PubMed ID: 34455950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prokinetic agents.
    Reynolds JC; Putnam PE
    Gastroenterol Clin North Am; 1992 Sep; 21(3):567-96. PubMed ID: 1516959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin as a target for gastrointestinal motility disorders.
    Greenwood-Van Meerveld B; Kriegsman M; Nelson R
    Peptides; 2011 Nov; 32(11):2352-6. PubMed ID: 21453735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of prokinetic agents in special populations.
    Horn JR
    Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S27-9. PubMed ID: 8931828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.
    Jadallah KA; Kullab SM; Sanders DS
    World J Gastroenterol; 2014 Jul; 20(27):8898-909. PubMed ID: 25083062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prokinetic agents for lower gastrointestinal motility disorders.
    Longo WE; Vernava AM
    Dis Colon Rectum; 1993 Jul; 36(7):696-708. PubMed ID: 8348856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases.
    Katzka DA; Loftus EV; Camilleri M
    Clin Pharmacol Ther; 2012 Sep; 92(3):306-20. PubMed ID: 22828717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prokinetics and their use in gastroenterology.
    Dolina J; Hep A; Kunovský L; Konečný Š
    Vnitr Lek; 2018; 64(6):673-678. PubMed ID: 30223666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the pharmacology of gastrointestinal prokinetics.
    Tonini M
    Pharmacol Res; 1996; 33(4-5):217-26. PubMed ID: 8938012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prokinetics and fundic relaxants in upper functional GI disorders.
    Tack J
    Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and therapy for idiopathic dyspepsia.
    Tack J; Kindt S
    Curr Gastroenterol Rep; 2005 Dec; 7(6):437-44. PubMed ID: 16313872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
    Wiseman LR; Faulds D
    Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional and motor gastrointestinal disorders].
    Mearin F; Rey E; Balboa A
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():3-12. PubMed ID: 26520191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status and recommendations for pediatric clinical trials in functional gastrointestinal disorders].
    Ding Z; Xu X; Ke M
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):567-9. PubMed ID: 25224230
    [No Abstract]   [Full Text] [Related]  

  • 19. Prokinetics in gastroparesis.
    Acosta A; Camilleri M
    Gastroenterol Clin North Am; 2015 Mar; 44(1):97-111. PubMed ID: 25667026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
    Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.